Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Myeloma, Newly Diagnosed”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01782963
What this trial is testing

Lenalidomide/Bortezomib/Dexamethasone for Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma
Massachusetts General Hospital 50
Large-scale testing (Phase 3)Not Yet RecruitingNCT07735637
What this trial is testing

A Phase III, Multicentre Study to Evaluate Consolidation Treatment With AZD0120 Compared With ASCT, in Participants With Newly Diagnosed Multiple Myeloma Who Are Transplant Eligible (DURGA-6).

Who this might be right for
Newly Diagnosed Multiple Myeloma (NDMM)
AstraZeneca 750
Not applicableUnknownNCT05561049
What this trial is testing

Efficacy and Safety of Daratumumab in Combination With Bortezomib, Thalidomide, and Dexamethasone Regimens in Newly Diagnosed Multiple Myeloma

Who this might be right for
Newly Diagnosed Multiple Myeloma
The First Affiliated Hospital of Soochow University 120
Large-scale testing (Phase 3)Active Not RecruitingNCT05827016
What this trial is testing

Compare Iberdomide Maintenance Versus Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplant in Participants With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Bristol-Myers Squibb 1,230
Testing effectiveness (Phase 2)Active Not RecruitingNCT06169215
What this trial is testing

Comparing the Combination of Selinexor-Daratumumab-Velcade-Dexamethasone (Dara-SVD) With the Usual Treatment (Dara-RVD) for High-Risk Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
National Cancer Institute (NCI) 58
Post-approval studies (Phase 4)Not Yet RecruitingNCT07334535
What this trial is testing

Isa-VRD in TIE HRMM

Who this might be right for
Multiple Myeloma
Peking Union Medical College Hospital 117
Not applicableUnknownNCT06109233
What this trial is testing

A Perspective Study of the MRD-tailored Therapy in Patients With Newly Diagnosed Multiple Myeloma With Persistent Minimal Residual Disease After Initial Treatment

Who this might be right for
Multiple MyelomaMinimal Residual Disease
FengYan Jin 80
Testing effectiveness (Phase 2)Study completedNCT00054158
What this trial is testing

Combination Chemotherapy and Thalidomide in Treating Patients With Stage I, Stage II, or Stage III Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Roswell Park Cancer Institute 24
Testing effectiveness (Phase 2)Study completedNCT01936532
What this trial is testing

Safety and Efficacy Study of a Triplet Combination of MLN9708, Lenalidomide and Dexamethasone in the Initial Management of Multiple Myeloma (IFM2013-06)

Who this might be right for
Newly Diagnosed Multiple Myeloma
Nantes University Hospital 42
Testing effectiveness (Phase 2)Study completedNCT00410657
What this trial is testing

Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Fred Hutchinson Cancer Center 53
Not applicableNot Yet RecruitingNCT07018271
What this trial is testing

A Study on the Use of Sulpegfilgrastim to Prevent the Incidence of Neutropenia With Infection in Newly Diagnosed Non-transplant Multiple Myeloma Patients

Who this might be right for
Multiple MyelomaDRDSulpegfilgrastim+1 more
The First Affiliated Hospital of Soochow University 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT02773030
What this trial is testing

Determine Dose, Safety, Tolerability and Efficacy of CC-220 Monotherapy, and in Combination With Other Treatments in Subjects With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 466
Not applicableStudy completedNCT01454297
What this trial is testing

Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile

Who this might be right for
Multiple Myeloma
Multiple Myeloma Research Foundation 1,154
Testing effectiveness (Phase 2)Study completedNCT00793572
What this trial is testing

Autologous or Syngeneic Stem Cell Transplant Followed by Donor Stem Cell Transplant and Bortezomib in Treating Patients With Newly Diagnosed High-Risk, Relapsed, or Refractory Multiple Myeloma

Who this might be right for
Refractory Plasma Cell Myeloma
Fred Hutchinson Cancer Center 32
Large-scale testing (Phase 3)UnknownNCT03720041
What this trial is testing

Myeloma XIV: Frailty-adjusted Therapy in Transplant Non-Eligible Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Leeds 740
Large-scale testing (Phase 3)Study completedNCT00205751
What this trial is testing

Thalidomide/Dexamethasone vs MP for Induction Therapy and Thalidomide/Intron A vs Intron A for Maintenance Therapy

Who this might be right for
Multiple Myeloma
Austrian Forum Against Cancer 350
Testing effectiveness (Phase 2)Study completedNCT00287872
What this trial is testing

Bortezomib and Thalidomide in Treating Patients With Newly Diagnosed Stage II or Stage III Multiple Myeloma

Who this might be right for
Multiple Myeloma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 30
Testing effectiveness (Phase 2)Study completedNCT01383928
What this trial is testing

Study of Oral IXAZOMIB in Combination With Lenalidomide and Dexamethasone in Participants With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Millennium Pharmaceuticals, Inc. 64
Testing effectiveness (Phase 2)Looking for participantsNCT06758375
What this trial is testing

Low Dose Teclistamab in Newly Diagnosed Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma, Newly Diagnosed
Hospital Universitario Dr. Jose E. Gonzalez 10
Large-scale testing (Phase 3)Study completedNCT01916252
What this trial is testing

Bortezomib (Velcade®), Lenalidomide (Revlimid®) and IV Busulfan (Busilvex®) in Patients Under 65 Years Old

Who this might be right for
Multiple Myeloma
PETHEMA Foundation 460
Next Page